Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/220114
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDowiak, Alexis-
dc.contributor.authorWilliamson, Lane-
dc.contributor.authorPovilaikaite, Julija-
dc.contributor.authorCabrera, Edgar-
dc.contributor.authorAponte, Nelson-
dc.contributor.authorGarcia, Johnny-
dc.contributor.authorQuiroz, Lina-
dc.contributor.authorPiña, Martha-
dc.contributor.authorMartinez, Cindy-
dc.contributor.authorValencia, Diana-
dc.contributor.authorBarragan, Liliana-
dc.contributor.authorBenito Reséndiz, Alma-
dc.contributor.authorMagelssen, Henriette-
dc.contributor.authorTrujillo, Ángela-
dc.contributor.authorOsorio, Diana-
dc.contributor.authorFigueredo, Oscar-
dc.contributor.authorPacker, Roger-
dc.contributor.authorSarmiento, Isabel-
dc.contributor.authorSuarez, Amaranto-
dc.contributor.authorMushtaq, Naureen-
dc.contributor.authorAbdullaev, Zied-
dc.contributor.authorPoria, Dipak-
dc.contributor.authorBartels, Ute-
dc.contributor.authorBouffett, Eric-
dc.contributor.authorRivera Polo, Barbara-
dc.contributor.authorAldape, Kenneth-
dc.contributor.authorRamaswamy, Vijay-
dc.contributor.authorFonseca, Adriana-
dc.date.accessioned2025-03-31T08:13:30Z-
dc.date.available2025-03-31T08:13:30Z-
dc.date.issued2024-06-18-
dc.identifier.issn1523-5866-
dc.identifier.urihttps://hdl.handle.net/2445/220114-
dc.description21st International Symposium on Pediatric Neuro-Oncology (ISPNO), International Society of Paediatric Oncology (SIOP), Filadèlfia, EEUU, 28 de juny - 2 juliol 2024-
dc.description.abstractCentral nervous system (CNS) sarcomas are rare mesenchymal non-meningothelial tumors accounting for 0.2% of brain tumors. Due to their rarity, there is a lack of substantive clinical, histological and molecular data.-
dc.format.extent1 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherOxford University Press (OUP)-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1093/neuonc/noae064.200-
dc.relation.ispartofNeuro-Oncology, 2024, vol. 26, sup. 4, p. iv58-iv59-
dc.relation.urihttps://doi.org/10.1093/neuonc/noae064.200-
dc.rightscc-by-nc (c) Dowiak, Alexis et al., 2024-
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/es/*
dc.sourceComunicacions a congressos (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))-
dc.subject.classificationSarcoma-
dc.subject.classificationMutació (Biologia)-
dc.subject.classificationSistema nerviós central-
dc.subject.otherSarcoma-
dc.subject.otherMutation (Biology)-
dc.subject.otherCentral nervous system-
dc.titleETMR-30. Clinical and molecular characterization of dicer-mutant central nervous system sarcoma-
dc.typeinfo:eu-repo/semantics/conferenceObject-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.date.updated2024-10-16T08:27:41Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
Appears in Collections:Comunicacions a congressos (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
Dowiak.pdf227.67 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons